de Goldman Sachs Bio-Techne TECH Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 519 M | Comprar |
7,343,324
+5,399,790
| +278% | +USD 292 M | 0.05% | 402 |
|
|
2026
Q1 | USD 102 M | Comprar |
1,943,534
+250,692
| +15% | +USD 15 M | 0.01% | 1015 |
|
|
2025
Q4 | USD 100 M | Comprar |
1,692,842
+156,704
| +10% | +USD 9.5 M | 0.01% | 994 |
|
|
2025
Q3 | USD 85.5 M | Vender |
1,536,138
-130,099
| -8% | -USD 6.97 M | 0.01% | 1040 |
|
|
2025
Q2 | USD 85.7 M | Comprar |
1,666,237
+602,298
| +57% | +USD 30.3 M | 0.01% | 986 |
|
|
2025
Q1 | USD 62.4 M | Comprar |
1,063,939
+113,634
| +12% | +USD 7.7 M | 0.01% | 1080 |
|
|
2024
Q4 | USD 68.5 M | Comprar |
950,305
+199,093
| +27% | +USD 14.6 M | 0.01% | 1046 |
|
|
2024
Q3 | USD 60 M | Vender |
751,212
-107,661
| -13% | -USD 8.09 M | 0.01% | 1109 |
|
|
2024
Q2 | USD 61.5 M | Comprar |
858,873
+104,979
| +14% | +USD 7.73 M | 0.01% | 1027 |
|
|
2024
Q1 | USD 53.1 M | Comprar |
753,894
+19,557
| +3% | +USD 1.4 M | 0.01% | 1129 |
|
|
2023
Q4 | USD 56.7 M | Comprar |
734,337
+181,376
| +33% | +USD 11.9 M | 0.01% | 1102 |
|
|
2023
Q3 | USD 37.6 M | Vender |
552,961
-102,663
| -16% | -USD 8.11 M | 0.01% | 1300 |
|
|
2023
Q2 | USD 53.5 M | Comprar |
655,624
+225,835
| +53% | +USD 18.2 M | 0.01% | 1053 |
|
|
2023
Q1 | USD 31.9 M | Comprar |
429,789
+194,960
| +83% | +USD 15 M | 0.01% | 1392 |
|
|
2022
Q4 | USD 19.5 M | Comprar |
234,829
+21,481
| +10% | +USD 1.71 M | ﹤0.01% | 1987 |
|
|
2022
Q3 | USD 15.1 M | Vender |
213,348
-18,664
| -8% | -USD 1.61 M | ﹤0.01% | 2108 |
|
|
2022
Q2 | USD 20.1 M | Vender |
232,012
-45,280
| -16% | -USD 4.24 M | 0.01% | 1886 |
|
|
2022
Q1 | USD 30 M | Vender |
277,292
-224,820
| -45% | -USD 23.2 M | 0.01% | 1725 |
|
|
2021
Q4 | USD 64.9 M | Vender |
502,112
-20,176
| -4% | -USD 2.47 M | 0.01% | 1128 |
|
|
2021
Q3 | USD 63.3 M | Vender |
522,288
-330,244
| -39% | -USD 40.2 M | 0.01% | 1085 |
|
|
2021
Q2 | USD 96 M | Vender |
852,532
-174,952
| -17% | -USD 18.4 M | 0.02% | 757 |
|
|
2021
Q1 | USD 98.1 M | Comprar |
1,027,484
+191,100
| +23% | +USD 17.4 M | 0.02% | 662 |
|
|
2020
Q4 | USD 66.4 M | Vender |
836,384
-57,132
| -6% | -USD 4.14 M | 0.02% | 899 |
|
|
2020
Q3 | USD 55.3 M | Comprar |
893,516
+9,556
| +1% | +USD 622 k | 0.02% | 921 |
|
|
2020
Q2 | USD 58.4 M | Vender |
883,960
-55,364
| -6% | -USD 3.32 M | 0.02% | 844 |
|
|
2020
Q1 | USD 44.5 M | Comprar |
939,324
+114,204
| +14% | +USD 5.71 M | 0.02% | 948 |
|
|
2019
Q4 | USD 45.3 M | Comprar |
825,120
+50,072
| +6% | +USD 2.63 M | 0.01% | 1216 |
|
|
2019
Q3 | USD 37.9 M | Comprar |
775,048
+310,748
| +67% | +USD 15.6 M | 0.01% | 1297 |
|
|
2019
Q2 | USD 24.2 M | Vender |
464,300
-55,360
| -11% | -USD 2.79 M | 0.01% | 1705 |
|
|
2019
Q1 | USD 25.8 M | Vender |
519,660
-271,544
| -34% | -USD 12.2 M | 0.01% | 1652 |
|
|
2018
Q4 | USD 28.6 M | Vender |
791,204
-16,252
| -2% | -USD 679 k | 0.01% | 1511 |
|
|
2018
Q3 | USD 41.2 M | Comprar |
807,456
+222,408
| +38% | +USD 9.9 M | 0.01% | 1365 |
|
|
2018
Q2 | USD 21.6 M | Comprar |
585,048
+52,840
| +10% | +USD 2.02 M | 0.01% | 1817 |
|
|
2018
Q1 | USD 20.1 M | Vender |
532,208
-361,596
| -40% | -USD 12.8 M | 0.01% | 1852 |
|
|
2017
Q4 | USD 28.9 M | Comprar |
893,804
+101,068
| +13% | +USD 3.21 M | 0.01% | 1666 |
|
|
2017
Q3 | USD 24 M | Vender |
792,736
-402,396
| -34% | -USD 11.9 M | 0.01% | 1831 |
|
|
2017
Q2 | USD 35.1 M | Comprar |
1,195,132
+158,136
| +15% | +USD 4.32 M | 0.01% | 1504 |
|
|
2017
Q1 | USD 26.4 M | Comprar |
1,036,996
+73,556
| +8% | +USD 1.9 M | 0.01% | 1710 |
|
|
2016
Q4 | USD 24.8 M | Vender |
963,440
-209,244
| -18% | -USD 5.5 M | 0.01% | 1814 |
|
|
2016
Q3 | USD 32.1 M | Vender |
1,172,684
-1,168
| -0.1% | -USD 32.1 k | 0.01% | 1545 |
|
|
2016
Q2 | USD 33.1 M | Vender |
1,173,852
-84,076
| -7% | -USD 2.16 M | 0.01% | 1405 |
|
|
2016
Q1 | USD 29.7 M | Comprar |
1,257,928
+771,720
| +159% | +USD 17 M | 0.01% | 1430 |
|
|
2015
Q4 | USD 10.9 M | Comprar |
486,208
+162,380
| +50% | +USD 3.7 M | ﹤0.01% | 2182 |
|
|
2015
Q3 | USD 7.48 M | Vender |
323,828
-35,952
| -10% | -USD 902 k | ﹤0.01% | 2505 |
|
|
2015
Q2 | USD 8.86 M | Comprar |
359,780
+32,916
| +10% | +USD 822 k | ﹤0.01% | 2439 |
|
|
2015
Q1 | USD 8.2 M | Vender |
326,864
-55,760
| -15% | -USD 1.33 M | ﹤0.01% | 2467 |
|
|
2014
Q4 | USD 8.84 M | Vender |
382,624
-132,020
| -26% | -USD 3.02 M | ﹤0.01% | 2458 |
|
|
2014
Q3 | USD 12 M | Vender |
514,644
-51,440
| -9% | -USD 1.21 M | ﹤0.01% | 2213 |
|
|
2014
Q2 | USD 13.1 M | Comprar |
566,084
+168,576
| +42% | +USD 3.73 M | ﹤0.01% | 2142 |
|
|
2014
Q1 | USD 8.48 M | Comprar |
397,508
+150,144
| +61% | +USD 3.38 M | ﹤0.01% | 2516 |
|
|
2013
Q4 | USD 5.85 M | Comprar |
247,364
+12,028
| +5% | +USD 261 k | ﹤0.01% | 2898 |
|
|
2013
Q3 | USD 4.71 M | Comprar |
235,336
+126,216
| +116% | +USD 2.39 M | ﹤0.01% | 2995 |
|
|
2013
Q2 | USD 1.88 M | Comprar |
+109,120
| Nuevas | +USD 1.81 M | ﹤0.01% | 3789 |
|
Otros fondos que tienen TECH en su cartera
Posición de Goldman Sachs en TECH: resumen de T2 2026
Goldman Sachs aumentó su participación en Bio-Techne (TECH) en 278% durante T2 2026, al comprar aproximadamente USD 292 M y elevar la posición a 7,343,324 acciones con un valor de USD 519 M. La posición representa 0.05% de la cartera y ocupa el puesto #402.
Goldman Sachs reportó por primera vez una posición en TECH en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 601 fondos que sigue Wall St. Rank mantienen una posición en TECH.
- Al cierre de T2 2026, Goldman Sachs tenía 7,343,324 acciones de Bio-Techne con un valor de USD 519 M.
- Goldman Sachs compró 5,399,790 acciones de Bio-Techne en T2 2026, por un monto estimado de USD 292 M.
- Bio-Techne representó 0.05% de la cartera de Goldman Sachs en T2 2026 y fue su posición número 402.
- Goldman Sachs reportó por primera vez una posición en Bio-Techne en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 601 fondos que sigue Wall St. Rank tenían Bio-Techne en cartera.
Según el Informe 13F de Goldman Sachs correspondiente a T2 2026, presentado el 14 ago 2026.